<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">26522770</PMID><DateCompleted><Year>2016</Year><Month>10</Month><Day>11</Day></DateCompleted><DateRevised><Year>2022</Year><Month>01</Month><Day>29</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1872-9096</ISSN><JournalIssue CitedMedium="Internet"><Volume>124</Volume><PubDate><Year>2015</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Antiviral research</Title><ISOAbbreviation>Antiviral Res</ISOAbbreviation></Journal><ArticleTitle>Potent antiviral agents fail to elicit genetically-stable resistance mutations in either enterovirus 71 or Coxsackievirus A16.</ArticleTitle><Pagination><StartPage>77</StartPage><EndPage>82</EndPage><MedlinePgn>77-82</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.antiviral.2015.10.006</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0166-3542(15)30004-8</ELocationID><Abstract><AbstractText>Enterovirus 71 (EV71) and Coxsackievirus A16 (CVA16) are the two major causative agents of hand, foot and mouth disease (HFMD), for which there are currently no licenced treatments. Here, the acquisition of resistance towards two novel capsid-binding compounds, NLD and ALD, was studied and compared to the analogous compound GPP3. During serial passage, EV71 rapidly became resistant to each compound and mutations at residues I113 and V123 in VP1 were identified. A mutation at residue 113 was also identified in CVA16 after passage with GPP3. The mutations were associated with reduced thermostability and were rapidly lost in the absence of inhibitors. In silico modelling suggested that the mutations prevented the compounds from binding the VP1 pocket in the capsid. Although both viruses developed resistance to these potent pocket-binding compounds, the acquired mutations were associated with large fitness costs and reverted to WT phenotype and sequence rapidly in the absence of inhibitors. The most effective inhibitor, NLD, had a very large selectivity index, showing interesting pharmacological properties as a novel anti-EV71 agent.</AbstractText><CopyrightInformation>Copyright &#xa9; 2015 The Authors. Published by Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kelly</LastName><ForeName>James T</ForeName><Initials>JT</Initials><AffiliationInfo><Affiliation>School of Molecular and Cellular Biology, University of Leeds, Leeds, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Colibus</LastName><ForeName>Luigi</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Division of Structural Biology, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Elliott</LastName><ForeName>Lauren</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>School of Molecular and Cellular Biology, University of Leeds, Leeds, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fry</LastName><ForeName>Elizabeth E</ForeName><Initials>EE</Initials><AffiliationInfo><Affiliation>Division of Structural Biology, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stuart</LastName><ForeName>David I</ForeName><Initials>DI</Initials><AffiliationInfo><Affiliation>Division of Structural Biology, University of Oxford, Oxford, UK; Diamond Light Source, Didcot, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rowlands</LastName><ForeName>David J</ForeName><Initials>DJ</Initials><AffiliationInfo><Affiliation>School of Molecular and Cellular Biology, University of Leeds, Leeds, UK. Electronic address: d.j.rowlands@leeds.ac.uk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stonehouse</LastName><ForeName>Nicola J</ForeName><Initials>NJ</Initials><AffiliationInfo><Affiliation>School of Molecular and Cellular Biology, University of Leeds, Leeds, UK. Electronic address: n.j.stonehouse@leeds.ac.uk.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>G1000099</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>G1100525</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MR/N00065X/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>G100099</GrantID><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>10</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Antiviral Res</MedlineTA><NlmUniqueID>8109699</NlmUniqueID><ISSNLinking>0166-3542</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D036022">Capsid Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002213" MajorTopicYN="N">Capsid</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D036022" MajorTopicYN="N">Capsid Proteins</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018360" MajorTopicYN="N">Crystallography, X-Ray</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D024882" MajorTopicYN="N">Drug Resistance, Viral</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004770" MajorTopicYN="N">Enterovirus</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="N">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006232" MajorTopicYN="N">Hand, Foot and Mouth Disease</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008958" MajorTopicYN="N">Models, Molecular</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011487" MajorTopicYN="N">Protein Conformation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014709" MajorTopicYN="N">Vero Cells</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Capsid binding</Keyword><Keyword MajorTopicYN="N">Drug resistance</Keyword><Keyword MajorTopicYN="N">Fitness</Keyword><Keyword MajorTopicYN="N">Hand foot and mouth disease</Keyword><Keyword MajorTopicYN="N">VP1 pocket</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>4</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2015</Year><Month>9</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>10</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>11</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>11</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>10</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2015</Year><Month>12</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26522770</ArticleId><ArticleId IdType="pmc">PMC4678291</ArticleId><ArticleId IdType="doi">10.1016/j.antiviral.2015.10.006</ArticleId><ArticleId IdType="pii">S0166-3542(15)30004-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Arita M., Shimizu H., Nagata N., Ami Y., Suzaki Y., Sata T., Iwasaki T., Miyamura T. Temperature-sensitive mutants of enterovirus 71 show attenuation in cynomolgus monkeys. J.&#xa0;Gen. Virol. 2005;86:1391&#x2013;1401.</Citation><ArticleIdList><ArticleId IdType="pubmed">15831951</ArticleId></ArticleIdList></Reference><Reference><Citation>Benschop K.S., van der Avoort H.G., Duizer E., Koopmans M.P. Antivirals against enteroviruses: a critical review from a public-health perspective. Antivir. Ther. 2015;20:121&#x2013;130.</Citation><ArticleIdList><ArticleId IdType="pubmed">25643052</ArticleId></ArticleIdList></Reference><Reference><Citation>Dang M., Wang X., Wang Q., Wang Y., Lin J., Sun Y., Li X., Zhang L., Lou Z., Wang J., Rao Z. Molecular mechanism of SCARB2-mediated attachment and uncoating of EV71. Protein Cell. 2014;5:692&#x2013;703.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4145081</ArticleId><ArticleId IdType="pubmed">24986489</ArticleId></ArticleIdList></Reference><Reference><Citation>De Colibus L., Wang X., Spyrou J.A.B., Kelly J., Ren J., Grimes J., Puerstinger G., Stonehouse N., Walter T.S., Hu Z., Wang J., Li X., Peng W., Rowlands D.J., Fry E.E., Rao Z., Stuart D.I. More-powerful virus inhibitors from structure-based analysis of HEV71 capsid-binding molecules. Nat. Struct. Mol. Biol. 2014;21:282&#x2013;288.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4530014</ArticleId><ArticleId IdType="pubmed">24509833</ArticleId></ArticleIdList></Reference><Reference><Citation>De Colibus L., Wang X., Tijsma A., Neyts J., Spyrou J.A.B., Ren J., Grimes J.M., Puerstinger G., Leyssen P., Fry E.E., Rao Z., Stuart D.I. Structure elucidation of Coxsackievirus A16 in complex with GPP3 informs a systematic review of highly potent capsid binders to enteroviruses. PLoS Path. 2015 (In press)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4613828</ArticleId><ArticleId IdType="pubmed">26485389</ArticleId></ArticleIdList></Reference><Reference><Citation>Feil S.C., Hamilton S., Krippner G.Y., Lin B., Luttick A., Mcconnell D.B., Nearn R., Parker M.W., Ryan J., Stanislawski P.C., Tucker S.P., Watson K.G., Morton C.J. An orally available 3-Ethoxybenzisoxazole capsid binder with clinical activity against human rhinovirus. ACS Med. Chem. Lett. 2012;3:303&#x2013;307.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4025830</ArticleId><ArticleId IdType="pubmed">24900468</ArticleId></ArticleIdList></Reference><Reference><Citation>Fowler D.M., Araya C.L., Fleishman S.J., Kellogg E.H., Stephany J.J., Baker D., Fields S. High-resolution mapping of protein sequence- function relationships. Nat. Methods. 2010;7:741&#x2013;746.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2938879</ArticleId><ArticleId IdType="pubmed">20711194</ArticleId></ArticleIdList></Reference><Reference><Citation>Groarke J.M., Pevear D.C. Attenuated virulence of pleconaril-resistant coxsackievirus B3 variants. JID. 1999;179:1538&#x2013;1541.</Citation><ArticleIdList><ArticleId IdType="pubmed">10228078</ArticleId></ArticleIdList></Reference><Reference><Citation>Heinz B.A., Rueckert R.R., Shepard D.A., Dutko F.J., Mckinlay M.A., Fancher M., Rossmann M.G., Badger J., Smith T.J. Genetic and molecular analyses of that are resistant to an antiviral compound. Genetic and molecular analyses of spontaneous mutants of human rhinovirus 14 that are resistant to an antiviral compound. J.&#xa0;Virol. 1989;63:2476.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC250706</ArticleId><ArticleId IdType="pubmed">2542566</ArticleId></ArticleIdList></Reference><Reference><Citation>Katpally U., Smith T.J., Rhinovirus H. Pocket factors are unlikely to play a major role in the life cycle of human rhinovirus pocket factors are unlikely to play a major role in the life cycle of. J.&#xa0;Virol. 2007;81:6307.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1900100</ArticleId><ArticleId IdType="pubmed">17428846</ArticleId></ArticleIdList></Reference><Reference><Citation>Ke Y., Lin T. Modeling the ligand - receptor interaction for a series of inhibitors of the capsid protein of enterovirus 71 using several three-dimensional quantitative structure &#x2013; activity relationship techniques. J.&#xa0;Med. Chem. 2006;49:4517&#x2013;4525.</Citation><ArticleIdList><ArticleId IdType="pubmed">16854057</ArticleId></ArticleIdList></Reference><Reference><Citation>Kellogg E.H., Leaver-fay A., Baker D. Role of conformational sampling in computing mutation-induced changes in protein structure and stability. Proteins. 2011;79:830&#x2013;838.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3760476</ArticleId><ArticleId IdType="pubmed">21287615</ArticleId></ArticleIdList></Reference><Reference><Citation>Kouiavskaia D.V., Dragunsky E.M., Liu H., Oberste M.S., Collett M.S., Chumakov K.M. Original article immunological and pathogenic properties of poliovirus variants selected for resistance to antiviral drug V-073. Antivir. Ther. 2011;16:999&#x2013;1004.</Citation><ArticleIdList><ArticleId IdType="pubmed">22024515</ArticleId></ArticleIdList></Reference><Reference><Citation>Lacroix C., Qluerol-aud&#x131; J., Roche M., Franco D., Froeyen M., Guerra P., Terme T., Vanelle P., Verdaguer N., Neyts J., Leyssen P. A&#xa0;novel benzonitrile analogue inhibits rhinovirus replication. J.&#xa0;Antimicrob. Chemother. 2014;69:2723&#x2013;2732.</Citation><ArticleIdList><ArticleId IdType="pubmed">24948704</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu H., Roberts J.A., Moore D., Anderson B., Pallansch M.A., Pevear D.C., Collett M.S., Oberste M.S. Characterization of poliovirus variants selected for resistance to the antiviral compound V-073. Antimicrob. Agents Chemother. 2012;56:5568&#x2013;5574.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3486616</ArticleId><ArticleId IdType="pubmed">22890765</ArticleId></ArticleIdList></Reference><Reference><Citation>Mcminn P.C. Enterovirus 71 in the Asia-Pacific region: an emerging cause of acute neurological disease in young children. Neurol. J. Southeast Asia. 2003;8:57&#x2013;63.</Citation></Reference><Reference><Citation>Mosser A.G., Sgro J., Rueckert R.R. Distribution of drug resistance mutations in type 3 poliovirus identifies three regions involved in uncoating functions. Distribution of drug resistance mutations in type 3 poliovirus identifies three regions involved in uncoating Functions. J.&#xa0;Virol. 1994;68:8193.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC237285</ArticleId><ArticleId IdType="pubmed">7966611</ArticleId></ArticleIdList></Reference><Reference><Citation>Pevear D.C., Hayden F.G., Demenczuk T.M., Barone L.R., Mckinlay M.A., Collett M.S. Relationship of pleconaril susceptibility and clinical outcomes in treatment of common colds caused by rhinoviruses relationship of pleconaril susceptibility and clinical outcomes in treatment of common colds caused by rhinoviruses. Antimicrob. Agents Chemother. 2005;49:4492&#x2013;4499.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1280128</ArticleId><ArticleId IdType="pubmed">16251287</ArticleId></ArticleIdList></Reference><Reference><Citation>Pevear D.C., Tull T.M., Seipel M.E., Groarke M., Groarke J.M. Activity of pleconaril against enteroviruses. Act. Pleconaril Against Enteroviruses. 1999;43:2109&#x2013;2115.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC89431</ArticleId><ArticleId IdType="pubmed">10471549</ArticleId></ArticleIdList></Reference><Reference><Citation>Plevka P., Perera R., Cardosa J., Kuhn R.J., Rossmann M.G. Crystal structure of human enterovirus 71. Science. 2012;336:1218713.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3448362</ArticleId><ArticleId IdType="pubmed">22383808</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren J., Wang X., Hu Z., Gao Q., Sun Y., Li X., Porta C., Walter T.S., Gilbert R.J., Zhao Y., Axford D., Williams M., Mcauley K., Rowlands D.J., Yin W., Wang J., Stuart D.I., Rao Z., Fry E.E. Picornavirus uncoating intermediate captured in atomic detail. Nat. Commun. 2013;4:1929.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3709478</ArticleId><ArticleId IdType="pubmed">23728514</ArticleId></ArticleIdList></Reference><Reference><Citation>Rotbart H.A., Connell J.F.O., Mckinlay M.A. Treatment of human enterovirus infections. Antivir. Res. 1998;38:1&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pubmed">9613999</ArticleId></ArticleIdList></Reference><Reference><Citation>Salvati A.L., Dominicis A., De Tait S., Canitano A., Lahm A., Fiore L. Mechanism of action at the molecular level of the antiviral drug 3 ( 2H ) -Isoflavene against type 2 poliovirus mechanism of action at the molecular level of the antiviral drug 3 ( 2H ) -Isoflavene against type 2 poliovirus. Antimicrob. Agents Chemother. 2004;48:2233&#x2013;2243.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC415587</ArticleId><ArticleId IdType="pubmed">15155227</ArticleId></ArticleIdList></Reference><Reference><Citation>Shepard D. a, Heinz B. a, Rueckert R.R. WIN 52035-2 inhibits both attachment and eclipse of human rhinovirus 14. J.&#xa0;Virol. 1993;67:2245&#x2013;2254.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC240355</ArticleId><ArticleId IdType="pubmed">8383239</ArticleId></ArticleIdList></Reference><Reference><Citation>Shia K., Li W., Chang C., Hsu M., Chern J., Leong M.K., Tseng S., Lee C., Lee Y., Chen S., Peng K., Tseng H., Chang Y., Tai C., Shih S. Design, synthesis, and structure - activity relationship of pyridyl imidazolidinones: a novel class of potent and selective human enterovirus 71. J.&#xa0;Med. Chem. 2002;45:1644&#x2013;1655.</Citation><ArticleIdList><ArticleId IdType="pubmed">11931618</ArticleId></ArticleIdList></Reference><Reference><Citation>Shih S., Tsai M., Tseng S., Won K., Shia K., Li W., Chen G., Lee C., Lee Y., Peng K., Chao Y. Mutation in enterovirus 71 capsid protein VP1 confers resistance to the inhibitory effects of pyridyl imidazolidinone mutation in enterovirus 71 capsid protein VP1 confers resistance to the inhibitory effects of pyridyl imidazolidinone. Antimicrob. Agents Chemother. 2004;48:3523&#x2013;3529.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC514779</ArticleId><ArticleId IdType="pubmed">15328120</ArticleId></ArticleIdList></Reference><Reference><Citation>Tyka M.D., Keedy D. a, Andr&#xe9; I., Dimaio F., Song Y., Richardson D.C., Richardsonb J.S., Baker D. Landscape mapping. J.&#xa0;Mol. Biol. 2011;405:607&#x2013;618.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3046547</ArticleId><ArticleId IdType="pubmed">21073878</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X., Peng W., Ren J., Hu Z., Xu J., Lou Z., Li X., Yin W., Shen X., Porta C., Walter T.S., Evans G., Axford D., Owen R., Rowlands D.J., Wang J., Stuart D.I., Fry E.E., Rao Z. A&#xa0;sensor-adaptor mechanism for enterovirus uncoating from structures of EV71. Nat. Struct. Mol. Biol. 2012;19:424&#x2013;429.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3378640</ArticleId><ArticleId IdType="pubmed">22388738</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>